Stay updated on Umbralisib Plus Pembrolizumab in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Umbralisib Plus Pembrolizumab in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Umbralisib Plus Pembrolizumab in Hodgkin Lymphoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.
    Difference
    3%
    Check dated 2025-10-05T08:14:50.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No other substantive content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-28T03:00:34.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1; the 'Back to Top' element was removed as a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-13T16:54:50.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T14:33:48.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as updates to the terminology related to Hodgkins lymphoma and associated treatments. Notably, the revision number has been updated to v3.0.0.
    Difference
    3%
    Check dated 2025-08-30T11:19:46.000Z thumbnail image
  9. Check
    78 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:31:38.000Z thumbnail image

Stay in the know with updates to Umbralisib Plus Pembrolizumab in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Umbralisib Plus Pembrolizumab in Hodgkin Lymphoma Clinical Trial page.